Home›Companies›Biotech & Pharma›Dnp Therapeutics

DNP Therapeutics Inc.

Develops potential treatments for viral infections and neurodegenerative disorders.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Mar 23, 2026·Suggest an edit

About Dnp Therapeutics

Dnp Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2026 in Delaware. It has reported $470,000 raised in one offering on Form D since March 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 5, 2026Mar 23, 2026$470,000of $1.0M target7$67,143Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Dnp Therapeutics's Form D filed Mar 23, 2026.

RM
Randall Mazzarino
Founder and director

Sources

  1. SECDNP THERAPEUTICS INC filing history
  2. CompanyDNP Therapeutics home